Ensysce Biosciences (ENSCW) Treasury Shares (2022 - 2023)
Ensysce Biosciences (ENSCW) reported Treasury Shares of $63.0 for Q3 2023, down 99.62% year-over-year from $16500.0 in Q3 2022, and down 83.29% quarter-over-quarter from $377.0 in Q2 2023.
Ensysce Biosciences (ENSCW) Treasury Shares (2022 - 2023) Analysis & Trends
Ensysce Biosciences (ENSCW) has 2 years of Treasury Shares data on file, last reported at $63.0 in Q3 2023.
- Treasury Shares for Q3 2023 came in at $63.0, down 99.62% year-over-year; the trailing twelve-month figure through Sep 2023 was $63.0 (down 99.62% YoY), and the FY2022 annual result was $1003.0, changed N/A from the prior year.
- Treasury Shares retreated to $63.0 in Q3 2023 per ENSCW's latest filing, from $377.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $16500.0 in Q3 2022 and troughed at $63.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 63.00 |
| Sep 30, 2023 | 63.00 |
| Jun 30, 2023 | 377.00 |
| Jun 30, 2023 | 377.00 |
| Mar 31, 2023 | 691.00 |
| Mar 31, 2023 | 691.00 |
| Dec 31, 2022 | 1,003.00 |
| Dec 31, 2022 | 1,003.00 |
| Sep 30, 2022 | 16,500.00 |
| Sep 30, 2022 | 16,500.00 |